Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

26 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Proteomic Atlas of the Human Brain in Alzheimer’s Disease

ABSTRACT: Here we provide a proteomic resource comprising nine functionally distinct sections from three individuals clinically diagnosed with Alzheimer's disease, across a spectrum of disease progression. Using state-of-the-art mass spectrometry, we identify a core brain proteome that exhibits only small variance in expression, accompanied by a group of proteins that are highly differentially expressed in individual sections and broader regions. AD affected tissue exhibited slightly elevated levels of tau protein with similar relative expression to factors associated with the AD pathology. Substantial differences were identified between previous proteomic studies of mature adult brains and our aged cohort. Our findings suggest considerable value in examining specifically the brain proteome of aged human populations, with the goal of understanding ways in which neurological changes occur past full maturity. This resource can serve as a guide, as well as a point of reference for how specific regions of the brain are affected by aging.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Joshua J Cppm

PROVIDER: MSV000088400 | MassIVE | Wed Nov 17 09:15:00 GMT 2021

SECONDARY ACCESSION(S): PXD010603

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

Proteomic Atlas of the Human Brain in Alzheimer’s Disease

Project description:Here we provide a proteomic resource comprising nine functionally distinct sections from three individuals clinically diagnosed with Alzheimer's disease, across a spectrum of disease progression. Using state-of-the-art mass spectrometry, we identify a core brain proteome that exhibits only small variance in expression, accompanied by a group of proteins that are highly differentially expressed in individual sections and broader regions. AD affected tissue exhibited slightly elevated levels of tau protein with similar relative expression to factors associated with the AD pathology. Substantial differences were identified between previous proteomic studies of mature adult brains and our aged cohort. Our findings suggest considerable value in examining specifically the brain proteome of aged human populations, with the goal of understanding ways in which neurological changes occur past full maturity. This resource can serve as a guide, as well as a point of reference for how specific regions of the brain are affected by aging.

2019-02-13 | PXD010603 | Pride

Proteomic Atlas of the Human Brain in Alzheimer’s Disease

2020-01-09 | PXD012131 | Pride

Proteomic Atlas of the Human Brain in Alzheimer’s Disease

2021-11-16 | MSV000088398 | MassIVE

Next-Generation Sequencing identified piRNA profiles in healthy and Alzheimer’s-affected human brain

Project description:To investigate the presence of piRNAs and their potential functions in human brain and neurodegenerations, we performed the genomic profiling in Healthy Brain (HB) sample as well as Alzheimer-affected brain (AD) sample by adopting Next-Gen small RNA sequencing technology. Using deep sequencing of small RNAs, we identified an extensive catalogue of 564 and 451 mature piRNAs in HB and AD respectively. The piRNAs from each sample exhibited varied length distribution between 26-32 nts and are originated from different genomic locations. We found 149 piRNAs to be differentially expressed in Alzheimer’s disease which comprises of 146 up-regulated and 3 down-regulated piRNAs. Ours is the first study that reported the presence of piRNAs in healthy as well as Alzheimer’s disease-affected human brain. The extensive catalogue of human piRNAs detected in this study provides a useful resource for decrypting the involvement of piRNAs in neurological functions as well as neurodegenerations.

2017-01-28 | GSE85075 | GEO

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Hippocampus

Project description:Human brain tissue was obtained from the New Zealand Brain Bank from donors with Alzheimer's disease (AD) or age-matched controls (n=9/group). Mean post mortem delays were ~12h. Six distinct brain regions were dissected, Hippocampus, Cingulate Gyrus, Entorhinal Cortex (severely affected), Motor and Sensory Cortex (less affected) and Cerebellum (spared). Protein was extracted from each sample and, each region was analysed independently. For each region, samples were divided into 3 sets of 3 cases and 3 controls and assigned to an iTRAQ 8 plex, alongside two aliquots of a pooled QC sample. Samples were digested, iTRAQ labelled and analysed. For each region, between 3000 and 4200 proteins were compared between AD and control, identifying a series of known and novel protein expression changes associated with the progression of AD.

2019-02-15 | PXD008739 | Pride

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Cerebellum

2019-02-15 | PXD008755 | Pride

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Entorhinal Cortex

2019-02-15 | PXD008765 | Pride

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Cingulate Gyrus

2019-02-15 | PXD008779 | Pride

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Entorhinal cortec

2019-02-15 | PXD008806 | Pride

Localised protein expression changes in different regions of human Alzheimer’s brain correlate with disease severity - Motor cortex

2019-02-15 | PXD008807 | Pride